US · Healthcare · Medical Distribution
EPS came in at 4.75 against a street estimate of 4.73 — a beat of 0.4%.
Analysts rate Cencora Inc. a buy (12 buy, 2 hold, 0 sell out of 14) with an average price target of $356.67.
| Fund | Stake |
|---|---|
| BlackRock Inc | 10.25% |
| Vanguard Capital Management, LLC | 6.33% |
| Vanguard Portfolio Management, LLC | 4.93% |
| State Street Corp | 4.72% |
| T. Rowe Price Associates, Inc. | 3.76% |
| FMR Inc | 3.44% |
| T. Rowe Price Investment Management,Inc. | 3.24% |
| Geode Capital Management, LLC | 2.86% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-06-15 |
| Board / officer change · Q2 2026 | 2026-05-29 |
| Quarterly report · Q1 2026 | 2026-05-06 |
| Results announced · Q2 2026 | 2026-05-06 |
| Reg FD disclosure · Q1 2026 | 2026-03-23 |
| Quarterly report · Q4 2025 | 2026-02-04 |
| Proxy statement · Q1 2026 | 2026-01-22 |
| Annual report FY2025 | 2025-11-25 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.60 / share ex-date May 15, 2026 · pay Jun 1, 2026 | 2026-05-15 |
| Dividend | $0.60 / share ex-date Feb 13, 2026 · pay Mar 2, 2026 | 2026-02-13 |
| Dividend | $0.60 / share ex-date Nov 14, 2025 · pay Dec 1, 2025 | 2025-11-14 |
| Dividend | $0.55 / share ex-date Aug 15, 2025 · pay Sep 3, 2025 | 2025-08-15 |
| Announcement | Date |
|---|---|
| Entered into definitive agreement to acquire EyeSouth Partners' retina business Cencora, Inc. announced on March 23, 2026, that it has signed a definitive agreement to acquire EyeSouth Partners' retina business. The agreement was finalized on March 21, 2026. No specific | 2026-03-23 |
| Animal health business to merge with Covetrus in $3.5B deal Cencora announced it is merging its animal health business, MWI Animal Health, with Covetrus, Inc. in a deal valued at $3.5 billion enterprise value. Cencora will receive $1.25 billion in up | 2026-02-18 |
| Acquired majority equity interest in OneOncology for $4.6 billion Cencora, Inc. announced its Q1 fiscal 2026 earnings (quarter ended December 31, 2025) on February 4, 2026. The company also announced a major acquisition: it bought the majority stake in One | 2026-02-04 |
| Secured $1.5B term loan facility for OneOncology majority stake acquisition Cencora announced three financing arrangements on January 12, 2026, totaling $5.5 billion to fund its acquisition of the majority stake in OneOncology (a cancer care platform it doesn't curr | 2026-01-16 |
| Agreed to acquire majority equity interests in OneOncology from TPG Cencora announced on December 15, 2025, that it will acquire the majority stake in OneOncology (a physician-led oncology practice platform) that it doesn't already own from investment firm T | 2025-12-15 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cencora Inc. — free to start.
Google PlayApp StoreData updated 2026-08-05.